Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

DNA mismatch repair enzymes (for example, MSH2) maintain genomic integrity, and their deficiency predisposes to several human cancers and to drug resistance. We found that leukemia cells from a substantial proportion of children (∼11%) with newly diagnosed acute lymphoblastic leukemia have low or undetectable MSH2 protein levels, despite abundant wild-type MSH2 mRNA. Leukemia cells with low levels of MSH2 contained partial or complete somatic deletions of one to four genes that regulate MSH2 degradation (FRAP1 (also known as MTOR), HERC1, PRKCZ and PIK3C2B); we also found these deletions in individuals with adult acute lymphoblastic leukemia (16%) and sporadic colorectal cancer (13.5%). Knockdown of these genes in human leukemia cells recapitulated the MSH2 protein deficiency by enhancing MSH2 degradation, leading to substantial reduction in DNA mismatch repair and increased resistance to thiopurines. These findings reveal a previously unrecognized mechanism whereby somatic deletions of genes regulating MSH2 degradation result in undetectable levels of MSH2 protein in leukemia cells, DNA mismatch repair deficiency and drug resistance.

• Publication year

  2011

• Venue

  Nature Medicine

• Publication date

  2011-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2430PMID 21946537PMCID 3192247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of mismatch repair and genomic stability by miR-155

  2010cited by this paper
• Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management

  2009cited by this paper
• Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• DNA repair alterations in common pediatric malignancies.

  2008cited by this paper
• Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease

  2008cited by this paper
• Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer

  2008cited by this paper
• CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

  2008cited by this paper
• Phosphoinositide 3-kinase-dependent regulation of phospholipase Cgamma.

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• Role of class II phosphoinositide 3-kinase in cell signalling.

  2007cited by this paper
• Constitutive deficiency in DNA mismatch repair

  2007cited by this paper
• ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

  2006cited by this paper
• TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase*

  2006cited by this paper
• A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

  2006cited by this paper
• hMutS alpha is protected from ubiquitin-proteasome-dependent degradation by atypical protein kinase C zeta phosphorylation.

  2005cited by this paper
• hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation

  2005cited by this paper
• Inherited susceptibility to colorectal cancer.

  2005cited by this paper
• Degadration of mismatch repair hMutSα heterodimer by the ubiquitin‐proteasome pathway

  2004cited by this paper
• Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

  2004cited by this paper
• Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

  2004cited by this paper
• Acute lymphoblastic leukemia.

  2004cited by this paper
• Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

  2003cited by this paper
• Msh2 deficiency attenuates but does not abolish thiopurine hematopoietic toxicity in msh2-/- mice.

  2003cited by this paper
• Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers

  2002cited by this paper
• Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

  2002cited by this paper
• Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

  2001cited by this paper
• Regulation of translation initiation by FRAP/mTOR.

  2001cited by this paper
• TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

  2001cited by this paper
• Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis

  2000cited by this paper
• Induction of Two DNA Mismatch Repair Proteins, MSH2 and MSH6, in Differentiated Human Neuroblastoma SH‐SY5Y Cells

  1999cited by this paper
• Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.

  1999cited by this paper
• Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.

  1999cited by this paper
• Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers.

  1999cited by this paper
• Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents.

  1998cited by this paper
• Mouse models for hereditary nonpolyposis colorectal cancer.

  1998cited by this paper
• Mismatch repair deficiency associated with overexpression of the MSH3 gene.

  1998cited by this paper
• Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.

  1998cited by this paper
• Protein phosphatase 2A is a critical regulator of protein kinase C ζ signaling targeted by SV40 small t to promote cell growth and NF‐κB activation

  1997cited by this paper
• Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation.

  1997cited by this paper
• p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins.

  1996cited by this paper
• Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine

  1996cited by this paper
• The role of DNA mismatch repair in platinum drug resistance.

  1996cited by this paper
• Measurement of Heteroduplex Repair in Human Cell Extracts

  1995cited by this paper
• Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage

  1993cited by this paper
• The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

  1993cited by this paper
• Acute lymphoblastic leukemia.

  1982cited by this paper

• Harnessing mismatch repair deficiency for therapeutic targeting in cancers

  2025cites this paper
• Treatment-related mutagenic processes in acute lymphoblastic leukemia

  2025influential citation
• DNA repair and the contribution to chemotherapy resistance

  2025cites this paper
• Therapeutic 6-thio-deoxyguanosine inhibits telomere elongation in cancer cells by inducing a non-productive stalled telomerase complex

  2025cites this paper
• The role of HECT-type E3 ubiquitin ligases in DNA damage response and repair

  2025cites this paper
• Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy.

  2025cites this paper
• Chemotherapeutic 6-thio-2’-deoxyguanosine selectively targets and inhibits telomerase by inducing a non-productive telomere-bound telomerase complex

  2025cites this paper
• Aberrant DNA methylation in adult B-cell acute lymphoblastic leukemia and the therapeutic potential of hypomethylating agents

  2025cites this paper
• Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations

  2024cites this paper
• T‐cell lymphoblastic lymphoma in constitutional mismatch repair deficiency (CMMRD): Exploring treatment opportunities

  2024cites this paper
• Star wars against leukemia: attacking the clones

  2024cites this paper
• Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia

  2023cites this paper
• The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN

  2023cites this paper
• Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway.

  2023cites this paper
• RETRACTED ARTICLE: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4

  2022cites this paper
• Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

  2022cites this paper
• The role of DNA mismatch repair in immunotherapy of human cancer

  2022cites this paper
• Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours

  2022cites this paper
• A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor

  2022cites this paper
• Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy

  2022cites this paper
• TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells

  2022cites this paper
• The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation

  2022cites this paper
• Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2

  2021cites this paper
• The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner

  2021cites this paper
• High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

  2021cites this paper
• The impact of rare germline variants on human somatic mutation processes

  2021cites this paper
• Differential mRNA and long noncoding RNA expression profiles in pediatric B-cell acute lymphoblastic leukemia patients

  2021cites this paper
• Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies

  2021cites this paper
• DNA mismatch repair in mammals

  2021cites this paper
• Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse

  2021cites this paper
• PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia.

  2021cites this paper
• Mutational signatures are markers of drug sensitivity of cancer cells

  2021cites this paper
• A study of deregulated MMR pathways and anticancer potential of curcuma derivatives using computational approach

  2021cites this paper
• Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

  2021cites this paper
• Deregulation of MMR-Related Pathways and Anticancer Potential of Curcuma Derivatives– A Computational Approach

  2021cites this paper
• Dynamics of leucocyte DNA thioguanine nucleotide levels during maintenance therapy of childhood acute lymphoblastic leukemia

  2021cites this paper
• HERC1 Regulates Breast Cancer Cells Migration and Invasion

  2020cites this paper
• DNA repair pathways as guardians of the genome: Therapeutic potential and possible prognostic role in hematologic neoplasms.

  2020cites this paper
• Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma

  2020cites this paper
• DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers

  2020cites this paper
• Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

  2020cites this paper
• Drugs Against Cancer: Stories of Discovery and the Quest for a Cure

  2020cites this paper
• Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy

  2020cites this paper
• Genetic Alterations and Checkpoint Expression: Mechanisms and Models for Drug Discovery.

  2020cites this paper
• Proteogenomic heterogeneity of localized human prostate cancer progression

  2020cites this paper
• Phospho-Proteomic Discovery of Novel EPO Signal Transducers Including TXNIP as a Mediator of EPO- Dependent Human Erythropoiesis.

  2020cites this paper
• HERC Ubiquitin Ligases in Cancer

  2020influential citation
• Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis

  2020cites this paper
• Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

  2020cites this paper
• Phospho-Proteomic Discovery of Novel EPO Signal Transducers Including TXNIP as a Mediator of EPO- Dependent Human Erythropoiesis

  2020cites this paper
• Convergent network effects along the axis of gene expression during prostate cancer progression

  2020cites this paper
• DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells.

  2020cites this paper
• Getting Lost in the Cell–Lysosomal Entrapment of Chemotherapeutics

  2020cites this paper
• Pharmacogenomics

  2019cites this paper
• Epigenetic loss of heterozygosity of Apc and an inflammation-associated mutational signature detected in Lrig1+/--driven murine colonic adenomas

  2019cites this paper
• A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1

  2019cites this paper
• HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma

  2019cites this paper
• Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.

  2019cites this paper
• Next-generation characterization of the Cancer Cell Line Encyclopedia

  2019cites this paper
• Mechanisms of NT5C2-Mediated Thiopurine Resistance in Acute Lymphoblastic Leukemia

  2019cites this paper
• HERCing: Structural and Functional Relevance of the Large HERC Ubiquitin Ligases

  2019cites this paper
• 1 Panel-based Next-generation Sequencing Identifies Prognostic and Actionable Genes in Childhood 1 Acute Lymphoblastic Leukemia and is Suitable for Clinical Sequencing 2 3

  2018influential citation
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing

  2018cites this paper
• Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer

  2018cites this paper
• The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation

  2018cites this paper
• MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia

  2018cites this paper
• Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.

  2018cites this paper
• MSH2 deletion with CREBBP and KRAS mutations in pediatric high‐hyperdiploid acute lymphoblastic leukemia

  2017cites this paper
• Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells

  2017cites this paper
• Class II Phosphoinositide 3-Kinases as Novel Drug Targets.

  2017cites this paper
• Staphylococcus aureus Triggers Induction of miR-15B-5P to Diminish DNA Repair and Deregulate Inflammatory Response in Diabetic Foot Ulcers.

  2017cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification

  2017cites this paper
• Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis

  2017cites this paper
• New targeted therapies for relapsed pediatric acute lymphoblastic leukemia

  2017cites this paper
• SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia.

  2017cites this paper
• A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors

  2017cites this paper
• Chapter 18 DNA Repair and Resistance to Cancer Therapy

  2017cites this paper
• De-regulation of microRNA and gene expression in diabetic foot ulcers lead to a dampened inflammatory response, inefficient DNA repair and inhibition of cell migration

  2016cites this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cites this paper
• Msh2 deficiency leads to dysmyelination of the corpus callosum, impaired locomotion, and altered sensory function in mice

  2016cites this paper
• Maintenance therapy of childhood acute lymphoblastic leukemia revisited—Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

  2016cites this paper
• Functional and pathological relevance of HERC family proteins: a decade later

  2016influential citation
• Approaches to diagnose DNA mismatch repair gene defects in cancer.

  2016cites this paper
• The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination

  2016cites this paper
• NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

  2016cites this paper
• An Integrated Approach for RNA-seq Data Normalization

  2016cites this paper
• An investigation of the pharmacogenetic basis of toxicity to platinum chemotherapy agents

  2016cites this paper
• DNA Mismatch Repair in Mammals

  2016cites this paper
• Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

  2015cites this paper
• Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia

  2015cites this paper
• PI3K regulatory subunit p85alpha plays a tumor suppressive role in the transformation of mammary epithelial cells

  2015cites this paper
• Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.

  2015cites this paper
• Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.

  2015cites this paper
• Differentiating Lynch-like from Lynch syndrome.

  2014cites this paper
• Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  2014cites this paper
• PKCζ and PKMζ are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity

  2014cites this paper
• Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia

  2014cites this paper
• Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.

  2014cites this paper